Cisterna Biologics Patents

Patent portfolio assigned to Cisterna Biologics (verified via public assignee records). Estimated patent count: 1. mRNA quality/purification (SPECC ribozyme tech), YC, San Diego/Carlsbad. Patent application US20230392176 'Method of purifying mRNA using substrate dependent ribozyme and solid-support attachment tag' matches Cisterna's SPECC tech and claims priority to provisional 63/349,190 (filed 2022-06-06); founder Hari Bhaskaran has industry patents. Could not fetch Google Patents/Justia page to print assignee verbatim (503/403), so assignee not confirmed word-for-word. Competitors are mRNA reagent/CDMO peers per CleanCap CDMO landscape sources.